Releases
Aether Holdings is facing scrutiny from the law firm Pomerantz LLP, which is probing potential securities fraud following allegations that the company operated as a sophisticated pump-and-dump scheme. The investigation centers on claims of deceptive business practices and false filings that surfaced shortly after the firm's 2025 public offering.
Releases
A 7.16% drop in Medline Industries’ stock price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows a June 2, 2026, U.S. Food and Drug Administration warning letter citing significant violations of manufacturing regulations and failures to investigate unexplained batch discrepancies at the firm.
Releases
A 32.78% drop in share price has triggered a class action lawsuit against ZoomInfo Technologies Inc. Investors who suffered losses after the company slashed its 2026 financial guidance now have until August 25, 2026, to petition the court to serve as lead plaintiff in the ongoing securities fraud litigation.
Releases
Identiv shares plummeted 32% after the company announced plans to divest its Internet of Things assets and Thai subsidiary to Trackonomy Systems. The deal, which requires Identiv to contribute $25 million in cash for $50 million in preferred equity, has prompted a formal investigation by the law firm Pomerantz LLP.
Releases
Investors in Datavault AI Inc. are under scrutiny as New York-based law firm Pomerantz LLP begins an investigation into potential securities fraud. The inquiry centers on allegations that the company misled shareholders regarding its core technology claims and business operations, following a damaging report from Wolfpack Research.
Releases
A 23.91% collapse in ARS Pharmaceuticals stock following a failed insurance coverage announcement has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the company and its leadership misled shareholders regarding the commercial prospects of its flagship nasal epinephrine spray, neffy.
Releases
A 19.6% single-day stock drop has triggered a formal investigation into Cerebras Systems Inc. as legal counsel probes potential securities fraud. The inquiry follows the company’s recent quarterly report, which revealed financial results that fell significantly short of market expectations, leaving investors questioning the accuracy of earlier disclosures.
Releases
Shares of Hertz Global Holdings plummeted 40.71% on June 24, 2026, after the company disclosed a $300 million private offering of exchangeable senior notes. Following the sharp market reaction, the New York-based Pomerantz LLP has opened an investigation into potential securities fraud and unlawful business practices by company leadership.
Releases
Eighty-five percent of visible eye aging stems from environmental factors rather than genetics alone. Addressing this, French prestige brand Clarins is launching a new iteration of its Double Serum Eye, utilizing seven years of epigenetic research to combat the cumulative effects of pollution, fatigue, and daily habits on the eye contour.
Releases
A 5.67% single-day share price drop following a sudden strategic reset has triggered a formal investigation by Pomerantz LLP. The firm is currently reviewing potential securities fraud and fiduciary breaches at Portillo's Inc., specifically targeting whether leadership misled investors regarding the company’s 2025 financial and operational growth targets.
Releases
A 19 percent single-day stock drop and the abrupt departure of its finance chief have triggered a formal investigation into Certara, Inc. The Pomerantz Law Firm is now reviewing potential securities fraud claims, probing whether the company’s leadership misled investors regarding the stability of its service segment performance.
Releases
Investors in Alamos Gold Inc. are under scrutiny by the Pomerantz Law Firm following a sharp double-digit decline in the company's share price. Legal counsel is currently examining whether the mining firm or its leadership engaged in securities fraud or unlawful business practices after disclosing significant operational setbacks.
Releases
A 20 percent single-day stock drop for NovoCure Limited has triggered a formal securities fraud investigation by Pomerantz LLP. The inquiry follows the announcement of failed Phase 3 trial results, which saw the company’s share price plummet to 14.28 dollars after the firm’s experimental glioblastoma therapy missed its primary survival endpoint.
Releases
Texas Attorney General Ken Paxton’s inquiry into the marketing of high-caffeine energy drinks to minors has triggered a broader legal response. New York-based Pomerantz LLP is now investigating potential securities fraud at Celsius Holdings, Inc., following accusations that the company misrepresented product safety to investors and consumers alike.
Releases
Kevin Miller and JP Sio have launched Peptide Tracker on the Google Play Store, offering Android users a dedicated interface for managing peptide protocols. The app eliminates the need for spreadsheets by centralizing dose logging, vial inventory, and reconstitution math into a single, ad-free mobile environment.
Releases
Labcorp Holdings Inc. has confirmed a cash dividend of $0.72 per share for its common stock, signaling a continued commitment to shareholder returns. The payment is scheduled for distribution on September 11, 2026, targeting investors who hold positions in the company by the close of business on August 28.
Releases
A $555 million deal has reshaped the safety technology landscape, as Sentinel Capital Partners offloads its Norwegian fire and gas detection specialist, Autronica, to Pittsburgh-based MSA Safety. The move marks the latest exit for Sentinel, which has systematically dismantled its Spectrum Safety Solutions platform over the past several months.
Releases
A 93.4% collapse in share price on March 26, 2026, has triggered a class action lawsuit against Megan Holdings Limited. Investors who purchased securities during the company's initial public offering or subsequent months are now seeking legal recourse, alleging a coordinated stock manipulation scheme.
Releases
A midyear shopping festival has triggered legal scrutiny for JD.com, as New York-based Pomerantz LLP investigates the retail giant for potential securities fraud. The inquiry follows regulatory pressure in Beijing regarding the company's marketing conduct during the widely promoted '618' event, which previously impacted the firm's American Depositary Receipt price.
Releases
A sharp 14.57% drop in Starfighters Space stock has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows the sudden February resignation of founder Rick Svetkoff and his spouse, Brenda Svetkoff, who both cited irreconcilable disagreements with the company’s board over core operational policies.
Releases
Twelve parishes across Northeast Louisiana are moving toward a community-based mental health model, as the Northeast Delta Human Services Authority and Growing Hope Recovery unveil a coordinated mobile crisis system. The initiative aims to shift intervention away from emergency rooms and law enforcement, providing direct, specialized field support.
Releases
A federal class action lawsuit now challenges PicS N.V. over allegations of securities fraud, following a sudden shift in the company’s credit loss reporting that triggered a 22.5% collapse in share value. Investors who acquired stock during the initial public offering window face an August 4, 2026, deadline to seek lead plaintiff status.
Releases
A 28% single-day stock plunge has triggered a formal investigation into Better Home & Finance Holding Company. New York-based Pomerantz LLP is currently examining whether the digital mortgage lender and its leadership engaged in securities fraud or unlawful business practices following a shift in the firm’s growth outlook.
Releases
A 21.48% single-day stock plunge has triggered a formal investigation by Pomerantz LLP into DXC Technology Company. The legal inquiry centers on potential securities fraud and whether corporate leadership misled shareholders regarding the firm's financial performance and internal execution capabilities during the 2026 fiscal year.
Releases
Shares of Elicio Therapeutics plummeted by nearly 71% following the company’s admission that its flagship cancer treatment failed to meet key clinical trial benchmarks. The collapse has triggered a formal investigation by the New York-based law firm Pomerantz LLP, which is now probing potential securities fraud allegations.
Releases
A 17% plunge in stock price following a sharp reduction in fiscal year revenue guidance has triggered a formal investigation into Oxford Industries. New York-based Pomerantz LLP is now probing the company and its leadership for potential securities fraud or unlawful business practices linked to the recent financial shortfall.
Releases
Investors who purchased Roblox Corporation securities are facing a critical August 7, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation centers on allegations of securities fraud following a sharp decline in the company’s financial performance and market valuation earlier this spring.
Releases
Navigating the stringent regulatory landscape of the alcohol industry, ID Logistics has launched a specialized distribution facility in New Jersey. The greenfield site marks a strategic expansion for the global contract logistics firm, aiming to bolster its fulfillment footprint across the eastern United States market.
Releases
Investors who purchased Zillow securities during the current class period face an August 10, 2026, deadline to seek appointment as lead plaintiff in a new class action lawsuit. Pomerantz LLP alleges the company and its executives engaged in securities fraud related to undisclosed competitive practices and subsequent legal expenses.
Releases
Investors in SailPoint, Inc. face potential losses following a sharp stock decline on June 9, 2026, prompting a formal investigation by Pomerantz LLP. The inquiry centers on whether the company or its leadership misled shareholders regarding financial health and the impact of foreign-exchange volatility on future revenue growth.
